Diagnostic delay in psoriatic arthritis

Scope, consequences, and the role of dermatologist-led screening

Authors

  • D Thapa
  • U Bhattarai
  • R Baral

DOI:

https://doi.org/10.32674/yffar774

Keywords:

psoriatic arthritis, diagnostic delay, psoriasis; dermatologist, early detection, treatment guidelines

Abstract

Psoriatic arthritis develops in 25–30% of psoriasis patients. Diagnostic delays of one to five or more years are common, during which irreversible joint damage may accumulate. Despite validated screening tools and effective therapies, PsA remains substantially underdiagnosed in dermatology settings.

Downloads

Published

2025-12-31

Issue

Vol. 2 (2025): American Journal of Medicine and Health Studies

Section

Commentaries and Reports

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) [year] [author]
This work is licensed under a Creative Commons Attribution 4.0 International License.
This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. https://creativecommons.org/licenses/by/4.0

How to Cite

Diagnostic delay in psoriatic arthritis: Scope, consequences, and the role of dermatologist-led screening. (2025). American Journal of Medicine and Health Studies, 2, 63-80. https://doi.org/10.32674/yffar774